•
Jul 02, 2022

Waters Q2 2022 Earnings Report

Waters' second quarter performance in 2022 reflected strong execution and growth across all end-markets and major geographies.

Key Takeaways

Waters Corporation reported a 5% increase in sales to $714 million for the second quarter of 2022. Instrument sales grew by 12% in constant currency, and non-GAAP EPS increased by 6% to $2.75.

Sales of $714 million grew 5% as reported and 10% in constant currency.

Instrument sales grew 12% in constant currency, with double-digit growth across LC, MS and TA product lines.

Broad-based performance across all end-markets and major geographies, led by mid-teens growth in the U.S. and 9% constant currency growth in China.

GAAP EPS of $2.72; non-GAAP EPS of $2.75, a 6% increase from prior year.

Total Revenue
$714M
Previous year: $682M
+4.8%
EPS
$2.75
Previous year: $2.6
+5.8%
Pharma Market Sales
5%
Previous year: 416,705,000%
-100.0%
Industrial Market Sales
3%
Previous year: 202,579,000%
-100.0%
Academic & Gov Sales
10%
Previous year: 62,363,000%
-100.0%
Gross Profit
$407M
Previous year: $401M
+1.4%
Cash and Equivalents
$419M
Previous year: $460K
+90953.5%
Total Assets
$3.04B
Previous year: $3.1B
-2.0%

Waters

Waters

Waters Revenue by Geographic Location

Forward Guidance

The Company expects third quarter 2022 constant currency sales growth in the range of 8% to 10%. Currency translation is expected to decrease third quarter sales growth by approximately six percentage points. The Company expects third quarter 2022 non-GAAP EPS in the range of $2.50 to $2.60, which includes an estimated headwind of approximately 10% due to unfavorable foreign currency translation.

Revenue & Expenses

Visualization of income flow from segment revenue to net income